Corrigendum to “construction of bionanoparticles based on Angelica polysaccharides for the treatment of stroke” [nanomedicine: Nanotechnology, biology and medicine 44 (2022) 102570]

IF 4.2 2区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Nanomedicine : nanotechnology, biology, and medicine Pub Date : 2024-04-20 DOI:10.1016/j.nano.2024.102747

Yanguo Su MD , Chunjing Guo PhD , Qiang Chen MD , Huimin Guo MD , Jinqiu Wang BD , Mu Kaihang BD , Daquan Chen PhD

引用次数: 0

查看原文本刊更多论文

"基于当归多糖的仿生颗粒的构建用于治疗中风"[纳米医学：纳米技术、生物学和医学 44 (2022) 102570] 更正

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nanomedicine : nanotechnology, biology, and medicine 工程技术-纳米科技

CiteScore

11.10

自引率

0.00%

发文量

133

审稿时长

42 days

期刊介绍： The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.